HIGHLIGHTS
- who: Cecu00edlia Melo-Alvim and colleagues from the Department of Medical Oncology, Centro Hospitalar Universitu00e1rio Norte, have published the article: Radiotherapy, Chemotherapy and Immunotherapyu2014Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma, in the Journal: Diagnostics 2023, 13, 99. of /2023/
- what: The aim is to provide an overview of available treatment options and address future therapeutic perspectives. In patients with low estimated survival (up to 4 months) unfit for other cancer treatments, the main goal is comfort and symptom relief. This approach has shown promising results in soft tissue sarcoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.